Correspondence 0001493152-23-005157 from ZyVersa Therapeutics, Inc. (ZVSA)

ZyVersa Therapeutics, Inc.
Date: Feb. 15, 2023 · CIK: 0001859007 · Accession: 0001493152-23-005157

View on Edgar

AI Filing Summary & Sentiment

Date

February 13, 2023

Author

Managing Director

Form

CORRESP

Company

ZyVersa Therapeutics, Inc.

Letter

A.G.P./ALLIANCE GLOBAL PARTNERS

Madison Avenue 28th Floor New York,

New York 10022

February 15, 2023

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

F Street, N.E.

Washington, D.C. 20549

Re: ZyVersa Therapeutics, Inc. (the “Company”)

Registration Statement on Form S-1

File No. 333- 269442 (the “Registration Statement”)

Ladies and Gentlemen:

Reference is made to our letter filed as correspondence via EDGAR on February 13, 2023, in which we, as the lead placement agent, requested the acceleration of the effective date of the above-captioned Registration Statement for February 14, 2023 at 4:30 p.m. Eastern Time, in accordance with Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.

Very truly yours,
A.G.P./ALLIANCE GLOBAL PARTNERS

Show Raw Text

CORRESP
1
filename1.htm

A.G.P./ALLIANCE
GLOBAL PARTNERS

590
Madison Avenue 28th Floor New York,

New
York 10022

February
15, 2023

VIA
EDGAR

Securities
and Exchange Commission

Division
of Corporation Finance

100
F Street, N.E.

Washington,
D.C. 20549

    Re:
    ZyVersa Therapeutics, Inc. (the “Company”)

    Registration Statement on Form S-1

    File No. 333- 269442 (the “Registration Statement”)

Ladies
and Gentlemen:

Reference
is made to our letter filed as correspondence via EDGAR on February 13, 2023, in which we, as the lead placement agent, requested the
acceleration of the effective date of the above-captioned Registration Statement for February 14, 2023 at 4:30 p.m. Eastern Time, in
accordance with Rule 461 of the General Rules and Regulations of the U.S. Securities and Exchange Commission under the Securities Act
of 1933, as amended. We are no longer requesting that such Registration Statement be declared effective at this time and we hereby formally
withdraw our request for acceleration of the effective date.

    Very truly yours,

    A.G.P./ALLIANCE GLOBAL PARTNERS

    By:
    /s/ Thomas Higgins

    Name:
    Thomas Higgins

    Title:
    Managing Director

SecProbe.io